Biglycan deficiency interferes with ovariectomy-induced bone loss

Karina L Nielsen, Matthew R Allen, Susan A Bloomfield, Thomas L Andersen, Xiao-Dong Chen, Hans S Poulsen, Marian F Young, Anne-Marie Heegaard

    43 Citations (Scopus)

    Abstract

    Biglycan is a matrix proteoglycan with a possible role in bone turnover. In a 4-week study with sham-operated or OVX biglycan-deficient or wildtype mice, we show that biglycan-deficient mice are resistant to OVX-induced trabecular bone loss and that there is a gender difference in the response to biglycan deficiency.
    Original languageEnglish
    JournalJournal of Bone and Mineral Research
    Volume18
    Issue number12
    Pages (from-to)2152-8
    Number of pages7
    ISSN0884-0431
    DOIs
    Publication statusPublished - 2003

    Keywords

    • Animals
    • Biglycan
    • Bone Density
    • Carrier Proteins
    • Extracellular Matrix Proteins
    • Female
    • Glycoproteins
    • Male
    • Membrane Glycoproteins
    • Mice
    • Mice, Inbred C57BL
    • Mice, Knockout
    • Models, Animal
    • Osteoclasts
    • Osteoporosis
    • Osteoprotegerin
    • Ovariectomy
    • Proteoglycans
    • RANK Ligand
    • Receptor Activator of Nuclear Factor-kappa B
    • Receptors, Cytoplasmic and Nuclear
    • Receptors, Tumor Necrosis Factor

    Fingerprint

    Dive into the research topics of 'Biglycan deficiency interferes with ovariectomy-induced bone loss'. Together they form a unique fingerprint.

    Cite this